March 2013

 

ASCRS PREVIEW

 

April 19-23, 2013

Bringing guidance to all things glaucoma


by Vanessa Caceres EyeWorld Contributing Writer
   

ASCRS Glaucoma Day reaches attendees at a unique time in the subspecialty

Glaucoma Day co-planner Thomas W. Samuelson, M.D., says the day will focus heavily on minimally invasive glaucoma surgery, or MIGS. Source: EyeWorld

With the growing number of treatment options available for glaucoma, it's an exciting time to treat glaucoma patients. Surgeons looking to enhance their understanding of new as well as traditional treatmentsand gain perspective on glaucoma diagnosis, imaging, and cataracts in the glaucoma patientwon't want to miss ASCRS Glaucoma Day, to be held Friday, April 19, prior to the ASCRS•ASOA Symposium & Congress. Glaucoma Day will take place from 8:30 a.m. to 5 p.m. at San Francisco's Moscone Center.

The ASCRS Glaucoma Clinical Committee sponsors Glaucoma Day.

This year's program has an extra zing because of the new focus on microinvasive glaucoma surgery (MIGS), which was brought to the forefront with the U.S. Food and Drug Administration's approval of the iStent Trabecular Micro-Bypass Stent (Glaukos, Laguna Hills, Calif.), said Glaucoma Day co-planner Steven R. Sarkisian Jr., M.D., glaucoma, cataract and anterior segment surgeon; glaucoma fellowship director, Dean McGee Eye Institute; and clinical associate professor, University of Oklahoma, Oklahoma City.

"This will be the first ASCRS Glaucoma Day where panelists can discuss their U.S. experience implanting a MIGS device outside of a clinical trial," he said. "Glaucoma Day will heavily involve MIGS and how to select from the expanding array of glaucoma procedures," said co-planner Thomas W. Samuelson, M.D., Minnesota Eye Consultants, Minneapolis.

"We've generally had medicine and lasers on the conservative end, trabeculectomy and tube shunts on the aggressive end, and little in between. Now that we have less invasive options, we can go into that to a greater extent and discuss which procedure is best suited for which patient type."

The program

Glaucoma Day will kick off with a few talks focused on imaging, including topics such as "Avoiding pitfalls in glaucoma imaging" and "Anterior segment imaging in angle closure."

Following that will be a joint ASCRS/American Glaucoma Society symposium, "'Less' versus 'More'Improving your technique for challenging cases." "The joint symposium is always a highlight and it's somewhat of a debate style format," Dr. Samuelson said. Along with various speakers, the joint symposium will be moderated by Douglas J. Rhee, M.D., and Malik Y. Kahook, M.D.

Treatment for cataracts in glaucoma patients is a hot topic, and Kuldev Singh, M.D., will address the topic with his morning talk "Timely cataract surgery for optimal glaucoma management." Further discussion on glaucoma treatment options will take place with "First-line therapy: Emerging options, current thinking, and controversies," also to be moderated by Dr. Rhee. This part of the program will include a focus on subjects such as topical medications, next generation therapy, endoscopic cyclophotocoagulation, and controversies in medical and laser treatment.

Vish Padmanbhan, M.D., will present the award-winning video, "Lens removal: First line treatment for angle closure glaucoma." Glaucoma Day traditionally features the Stephen A. Obstbaum Honored Lecture, to be given this year by Garry P. Condon, M.D., associate professor, College of Medicine, Drexel University, Pittsburgh. Dr. Condon will speak about "Pseudoexfoliation: My life as a zonulist: What we know, don't know, and shouldn't show."

"Dr. Condon is always very entertaining and has a large surgical video library to draw from," Dr. Sarkisian said.

Dr. Condon said in his 25 years of practice, he has been involved with all realms of pseudoexfoliation management, which is often extremely challenging. He has seen these patients as glaucoma patients but also as referrals from cataract surgeons. He also said that surgeons need better guidance on how to manage late in-the-bag IOL dislocation in these patients, a phenomenon that may be occurring as patients live longer. "I'm going to touch on some of the things I've experienced, better ways to do things, caveats, and controversies," Dr. Condon said. During the afternoon's "Surgical glaucoma spotlight: Individualizing glaucoma surgery," a focus on "Cataract 'plus': trabecular bypass for early to moderate glaucoma" will address some of the newer MIGS technology. However, attendees will also get pearls to help with more traditional treatments. "The program committee has reviewed evaluations from past meetings, and we have decided to review some glaucoma surgery basics as well as new technology," Dr. Sarkisian said. The afternoon will wrap up with a talk on "Cataract surgery for the glaucoma patient: Strategies for success," given by Warren E. Hill, M.D., and "Video Complications: Targeting IOPCollateral damage with MIGS, tubes, and other 'big guns.'" Glaucoma Day traditionally ends with the video session, Dr. Samuelson said.

To learn more about Glaucoma Day or to register, go to ascrsglaucomaday.org/.

Editors' note: The physicians have no financial interests related to their comments.

Contact information

Condon: 412-359-6300, garrycondon@gmail.com
Samuelson: 612-813-3628, twsamuelson@mneye.com
Sarkisian: 405-271-1093, steven-sarkisian@dmei.org

Bringing guidance to all things glaucoma Bringing guidance to all things glaucoma
Ophthalmology News - EyeWorld Magazine
283 110
216 192
,
2016-07-08T15:40:38Z
True, 3